
When 10-year Treasury yields touch 5.058% and short and long rates jump together, the entire playbook for income, growth and capital protection gets rewritten in real time. Life insurers and annuity providers can sit close to the action because their businesses are tied to long-term yields, but not every stock benefits in the same way. This piece walks through three U.S. life and annuity stocks exposed to this rate shock and explains why each one might belong on your watchlist right now.
The three stocks below are just a small sample of the opportunity set, and the full screen surfaced 13 more U.S. life insurers and annuity providers with equally compelling narratives that are not covered here. To go straight to the source and identify your own high-conviction ideas, analyze the full U.S. Life Insurers and Annuity Providers Benefiting from Higher Long-Term Yields screener.
Primerica fits directly into this screener’s theme as a life insurer and annuity distributor focused on middle income households. Its mix of protection, savings products and fee revenue gives it a different rate sensitivity profile compared with many traditional bond heavy insurers.
Primerica serves middle income households with term life insurance, investment and savings products, and other financial services. Term life generates about US$1.8b of revenue, investment and savings contribute roughly US$1.4b and other distributed products about US$233m, with the stock valued around US$8.8b.
"Continued mix shift toward higher fee Investment & Savings Products, with that segment reaching about 42% of consolidated revenues in Q2 2026 and asset based revenues rising faster than underlying client asset values, increases the share of recurring, fee like income and can have a positive effect on consolidated revenue and earnings resilience."
The key factor now is how one pressure on Primerica’s cost base interacts with that richer stream of recurring fee income over time.
That pressure point is exactly where the full narrative for Primerica picks up, mapping how Primerica’s fee mix, capital needs and rate exposure could be quietly decoupling from headline rate moves.
UTG, Inc. is a U.S. life insurer that fits cleanly into the higher long-term yield theme, as it earns essentially all of its US$67 million in revenue from individual life policies in the United States and carries a market value of about US$182 million.
UTG provides focused exposure to U.S. life insurance tied to long-duration liabilities at a time when 10-year yields have pushed above 5%. Recent earnings rebounds indicate that its investment portfolio and underwriting mix may influence how much of that rate backdrop is reflected in future profitability if one currently unseen funding pressure changes direction.
If that funding pressure flips, you will want the 1 key reward and 2 important warning signs (2 are major!) to see how much upside or strain it could expose.
Citizens provides long duration life, living benefits and final expense cover that fits directly with a higher long term yield theme, with about US$173 million of revenue from international insurance and US$81 million from domestic policies. The stock is relatively small at around US$183 million in market value.
Citizens links its long duration life policies and reserves to the same higher long term yields that have pushed the 10 year Treasury above 5%, yet it still trades around a modest US$183 million market value. That combination of interest rate leverage and compact scale places significant importance on how one unresolved funding pressure evolves.
That funding question is exactly where the analysis report for Citizens picks up. It highlights where Citizens’ rate exposure and capital flexibility could quietly reshape the story.
Fresh ideas move first. By the time momentum is obvious, early entry points are already dropping away. Scan under the radar for now and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com